Kern Capital, a California-based financial services company, founded in 2020.
Location
Larkspur, CA, US
Founded
2020
Kern Capital manages a diversified portfolio with a focus on life sciences, investing in both new ventures and established businesses. The firm typically invests between $1 million to $10 million in a select few companies annually, seeking long-term partnerships with exceptional management teams. Kern Capital takes an active role on the boards of its portfolio companies without interfering in day-to-day operations.
Notable among Kern Capital's investments is Personal Genome Diagnostics, which has raised $103 million. The firm has participated in Series C funding rounds, demonstrating its commitment to supporting companies at later stages of growth. Kern Capital's approach emphasizes strategic partnerships and value-add beyond capital, leveraging its expertise to help portfolio companies succeed in their respective industries.
Kern Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Total Portfolio Exits1
Top Investment Stages
Series C1 (100.0%)
Stage Mix
Series C 100%
Concentration shown as share of disclosed investments by stage.
